fbpx

Vivos Therapeutics Inc

VVOS

$5.95

Closing

▲16.21%

1D

▲38.69%

YTD

VVOS

BBG00H1NZV85

Exchange

Sector

Market cap

$35.04M

Volume

103,045

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$35.04M

Analysts' Rating

BUY

Price Target (Mean)

6.30

Total Analysts

2

P/E

Operating Margin

-68.52%

Beta

7.47

Revenue Growth

16.93%

52 week high

$9.11

52 week low

$1.91

Div. Yield

%

EPS Growth

-33.33

Company Profile

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.